HC Wainwright Upgrades Aura Biosciences (NASDAQ:AURA) to “Buy”
Aura Biosciences (NASDAQ:AURA – Get Free Report) was upgraded by research analysts at HC Wainwright to a “buy” rating in a note issued to investors on Wednesday, Marketbeat reports. The brokerage presently has a $22.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 261.25% from the stock’s current price. […]
Aura Biosciences (NASDAQ:AURA – Get Free Report) was upgraded by research analysts at HC Wainwright to a “buy” rating in a note issued to investors on Wednesday, Marketbeat reports. The brokerage presently has a $22.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 261.25% from the stock’s current price. […]
